Selegiline: Difference between revisions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Comprehensive categorization: +Selective MAO-B inhibitors, Monoamine Oxidase Inhibitors (MAOIs) |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Antiparkinsonian Medicines -> Antiparkinsonism agents |
||
| Line 32: | Line 32: | ||
[[Category: | [[Category:Antiparkinsonism agents]] | ||
[[Category:Antiparkinsonian]] | [[Category:Antiparkinsonian]] | ||
[[Category:Selective MAO-B inhibitors]] | [[Category:Selective MAO-B inhibitors]] | ||
[[Category:Monoamine Oxidase Inhibitors (MAOIs)]] | [[Category:Monoamine Oxidase Inhibitors (MAOIs)]] | ||
Latest revision as of 00:37, 22 May 2026
Antiparkinsonian, MAO-B inhibitor
Selegiline
Eldepryl
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Antiparkinsonian, MAO-B inhibitor
Common uses
Pharmacy
Pharmacology
Purported mechanism
Irreversible selective MAO-B inhibitor